174 related articles for article (PubMed ID: 8420410)
1. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis.
Kadota J; Sakito O; Kohno S; Sawa H; Mukae H; Oda H; Kawakami K; Fukushima K; Hiratani K; Hara K
Am Rev Respir Dis; 1993 Jan; 147(1):153-9. PubMed ID: 8420410
[TBL] [Abstract][Full Text] [Related]
2. [Effect of erythromycin on intrapulmonary influx of neutrophils by intratracheal injection of lipopolysaccharide].
Sakito O; Kadota J; Oda H; Mukae H; Yokoyama A; Kawamoto S; Kaseda M; Morikawa T; Kusano S; Asai T
Kansenshogaku Zasshi; 1992 Feb; 66(2):194-200. PubMed ID: 1402080
[TBL] [Abstract][Full Text] [Related]
3. Erythromycin inhibits neutrophil chemotaxis in bronchoalveoli of diffuse panbronchiolitis.
Oda H; Kadota J; Kohno S; Hara K
Chest; 1994 Oct; 106(4):1116-23. PubMed ID: 7924482
[TBL] [Abstract][Full Text] [Related]
4. Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients.
Ichikawa Y; Ninomiya H; Koga H; Tanaka M; Kinoshita M; Tokunaga N; Yano T; Oizumi K
Am Rev Respir Dis; 1992 Jul; 146(1):196-203. PubMed ID: 1626803
[TBL] [Abstract][Full Text] [Related]
5. Increase in activated CD8+ cells in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis.
Mukae H; Kadota J; Kohno S; Kusano S; Morikawa T; Matsukura S; Hara K
Am J Respir Crit Care Med; 1995 Aug; 152(2):613-8. PubMed ID: 7633715
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil chemotactic activity in bronchoalveolar lavage fluid recovered from patients with diffuse panbronchiolitis.
Katsuki M
Kurume Med J; 1996; 43(4):279-87. PubMed ID: 9029897
[TBL] [Abstract][Full Text] [Related]
7. Significance of IL-1beta and IL-1 receptor antagonist (IL-1Ra) in bronchoalveolar lavage fluid (BALF) in patients with diffuse panbronchiolitis (DPB).
Kadota J; Matsubara Y; Ishimatsu Y; Ashida M; Abe K; Shirai R; Iida K; Kawakami K; Taniguchi H; Fujii T; Kaseda M; Kawamoto S; Kohno S
Clin Exp Immunol; 1996 Mar; 103(3):461-6. PubMed ID: 8608647
[TBL] [Abstract][Full Text] [Related]
8. Leukotriene B4 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis.
Oda H; Kadota J; Kohno S; Hara K
Chest; 1995 Jul; 108(1):116-22. PubMed ID: 7606944
[TBL] [Abstract][Full Text] [Related]
9. [Determination of the neutrophil chemotactic factor in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis].
Oda H; Kadota J; Sakito O; Mukae H; Morikawa N; Shukuwa C; Senju R; Sawa H; Kusano S; Morikawa T
Kansenshogaku Zasshi; 1992 Apr; 66(4):441-7. PubMed ID: 1624836
[TBL] [Abstract][Full Text] [Related]
10. Elevation of tumor-associated carbohydrate antigens in patients with diffuse panbronchiolitis.
Mukae H; Hirota M; Kohno S; Komori K; Fukushima K; Hiratani K; Kadota J; Hara K
Am Rev Respir Dis; 1993 Sep; 148(3):744-51. PubMed ID: 8103656
[TBL] [Abstract][Full Text] [Related]
11. [A mechanism of usefulness of treatment with erythromycin for diffuse panbronchiolitis].
Ichikawa Y; Ninomiya H; Koga H; Tokunaga N; Tanaka Y; Yano T; Oizumi K
Kansenshogaku Zasshi; 1991 Dec; 65(12):1501-7. PubMed ID: 1783799
[TBL] [Abstract][Full Text] [Related]
12. [A study of bronchoalveolar lavage analysis in patients with diffuse panbronchiolitis--the results of low dose and long term erythromycin treatment].
Mukae H; Sakito O; Oda H; Senju R; Hiratani K; Kadota J; Fukushima K; Komori K; Kouno S; Hara K
Kansenshogaku Zasshi; 1991 Jun; 65(6):692-7. PubMed ID: 1919099
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis or idiopathic pulmonary fibrosis.
Ogushi F; Tani K; Maniwa K; Ichikawa W; Tada H; Kawano T; Sone S
J Med Invest; 1997 Aug; 44(1-2):53-8. PubMed ID: 9395718
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy.
Sakito O; Kadota J; Kohno S; Abe K; Shirai R; Hara K
Respiration; 1996; 63(1):42-8. PubMed ID: 8833992
[TBL] [Abstract][Full Text] [Related]
15. Neutrophilia and high level of interleukin 8 in the bronchoalveolar lavage fluid of diffuse panbronchiolitis.
Koga T
Kurume Med J; 1993; 40(3):139-46. PubMed ID: 8139213
[TBL] [Abstract][Full Text] [Related]
16. [Effects of erythromycin on H2O2 generation by neutrophils].
Matsumoto K; Sugihara E; Ichikawa Y; Arikawa K; Honda J; Oizumi K
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jan; 35(1):3-8. PubMed ID: 9071149
[TBL] [Abstract][Full Text] [Related]
17. [Mechanism of efficacy of erythromycin on diffuse panbronchiolitis--effect of erythromycin on cytokine mRNA expression in human whole blood model].
Akiyoshi H; Honda J; Nakahara S; Tokisawa S; Tokunaga N; Ichikawa Y; Oizumi K
Kansenshogaku Zasshi; 1994 Feb; 68(2):209-16. PubMed ID: 8151147
[TBL] [Abstract][Full Text] [Related]
18. [Elastase activity in bronchoalveolar lavage fluid from patients with diffuse panbronchiolitis].
Ninomiya H; Ichikawa Y; Koga H; Yano T; Oizumi K
Kansenshogaku Zasshi; 1991 Jun; 65(6):672-80. PubMed ID: 1919096
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic characterization of T cells in bronchoalveolar lavage fluid (BALF) and peripheral blood of patients with diffuse panbronchiolitis; the importance of cytotoxic T cells.
Kawakami K; Kadota J; Iida K; Fujii T; Shirai R; Matsubara Y; Kohno S
Clin Exp Immunol; 1997 Feb; 107(2):410-6. PubMed ID: 9030883
[TBL] [Abstract][Full Text] [Related]
20. Cell profile and elastase activity in diffuse panbronchiolitis investigated by bronchoalveolar and bronchial lavage.
Yasuoka S; Fujisawa K; Ueta Y; Nii Y; Inoue I; Tani K; Ohgushi F; Ogura T
Intern Med; 1992 May; 31(5):599-605. PubMed ID: 1504421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
